SUMMARY Fifty-nine male patients and 41 female patients with uncomplicated gonorrhoea were treated with an intramuscular dose of 1600 mg sulphamethoxazole plus 320 mg trimethoprim followed by an oral dose of 2400 mg sulphamethoxazole plus 480 mg trimethoprim 12 hours later. Forty-nine out of 52 male patients and 37 out of 38 female patients who were re-examined were cured. One of the men probably had a reinfection.
Introduction
Csonka and Knight (1967) reported favourable results with a combination of trimethoprim and sulphamethoxazole in the treatment of gonorrhoea. Later several studies confirmed these results. Recently an intramuscular form of trimethoprimsulphamethoxazole has been developed which gives high blood concentrations of short duration. To obtain a high blood level for at least 24 hours we prescribed one intramuscular dose of trimethoprimsulphamethoxazole and one oral dose 12 hours later to evaluate its effect on uncomplicated gonorrhoea in patients of both sexes.
Material and methods
The series included 59 male and 41 female patients with uncomplicated gonorrhoea. Specimens for direct microscopy and culture were taken from the urethra in men and from the urethra, cervix, and rectal mucosa in women before treatment and at the follow-up visit seven to 14 days later. The specimens for culture were transported in Stuart's medium to the laboratory and cultured on two Thayer-Martin media, one of which also contained trimethoprim. Although treatment was given on the basis of positive microscopical evidence, only cases confirmed by culture (including fermentation reac-tions) were included in the assessment. Sensitivity tests to penicillin G and trimethoprim-sulphamethoxazole were carried out by the plate dilution method described by Reyn et al. (1958 The only side effect observed during the study was pain at the injection site in one patient; this disappeared after two days.
Discussion
The sensitivity-testing of the gonococci in the present study showed that fewer than 10% of the tested strains had a slightly decreased sensitivity to trimethoprim-sulphamethoxazole. The decreased sensitivity did not seem to cross-react with the decreased sensitivity to penicillin, which was about 25 % in the present series. It seems, therefore, that trimethoprim-sulphamethoxazole is a good substitute in cases in which penicillin is ineffective.
It seems evident that the plate dilution technique for trimethoprim-sulphamethoxazole gives adequate information on the clinically valuable sensitivities of gonococci for trimethoprim-sulphamethoxazole, at least with the present treatment schedule. All treatment failures (three patients) were infected by strains with MIC values of 1-25 and 25 ,ug/ml for trimethoprim-sulphamethoxazole, but no cases of treatment failure occurred in the group of patients with more sensitive gonococci.
The side effects were minimal; no allergic rashes were seen and only one patient had severe pain at the injection site.
Thus, the one-day treatment schedule we used for cases of uncomplicated gonorrhoea seemed to be effective and safe in patients of both sexes. 
